For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments
Heartflow is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product—an AI-driven, non-invasive cardiac test supported by the ACC/AHA Chest
About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatments in
Katalyst CRO is seeking a Lead Statistician in San Francisco, California. This role requires an individual with strong SAS programming skills and a master’s degree in a related field. You will be responsible for overseeing statistical analyses for
About Avalere Health United by one profound purpose: to reach EVERY PATIENT POSSIBLE. At Avalere Health, we ensure every patient is identified, treated, supported, and cared for. Equally. Our Advisory, Medical, and Marketing teams come together
About Charles River Associates Charles River Associates is a leading global consulting firm that provides economic, financial, and business management expertise to major law firms, corporations and governments around the world. CRA advises clients on economic
About Charles River Associates Charles River Associates is a leading global consulting firm that provides economic, financial, and business management expertise to major law firms, corporations and governments around the world. CRA advises clients on economic
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Patients are at the heart of everything we do. As part of our Medical Affairs team, you’ll foster internal and external collaboration to generate and disseminate evidence-based clinical practices to help impact patient lives and advance
Requisition ID # 172708 Job Category: Business Operations / Strategy Job Level: Individual Contributor Business Unit: Strategy & Growth Work Type: Hybrid Job Location: Dublin Position Summary The Senior Business Performance Analyst extracts operations data for
Requisition ID # 172712 Job Category: Business Operations / Strategy Job Level: Individual Contributor Business Unit: Strategy & Growth Work Type: Hybrid Job Location: Dublin Position Summary The Expert Business Performance Analyst extracts operations data for
Your Role The Actuarial Pay for Value team serves as a strategic partner to Blue Shield leadership in designing and advancing innovative payment models, value-based care strategies, provider incentives, and new program concepts that improve affordability,
Your Role The Actuarial Pay for Value team serves as a strategic partner to Blue Shield leadership in developing innovative payment models, value-based care strategies, and provider incentives that advance affordability, quality, provider performance, and member
We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Your Role The Network & Trend Analytics (NTA) team provides analytical and strategic support for BSC provider contract negotiations and performance management in collaboration with other departments. Our work is essential for us to fulfill our
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)